HEADER OXIDOREDUCTASE 09-FEB-06 2FZI TITLE NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII TITLE 2 AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TITLE 3 TRIMETHOPRIM DERIVATIVES COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PNEUMOCYSTIS CARINII; SOURCE 3 ORGANISM_TAXID: 4754; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: JM109 KEYWDS DIHYDROFOLATE REDUCTASE, TRIMETHOPRIM DERIVATIVES, RING STACKING KEYWDS 2 INTERACTIONS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR V.CODY,J.PACE,K.CHISUM,A.ROSOWSKY REVDAT 5 09-OCT-24 2FZI 1 REMARK REVDAT 4 30-AUG-23 2FZI 1 REMARK LINK REVDAT 3 20-NOV-13 2FZI 1 FORMUL HET HETATM HETNAM REVDAT 3 2 1 HETSYN VERSN REVDAT 2 24-FEB-09 2FZI 1 VERSN REVDAT 1 26-DEC-06 2FZI 0 JRNL AUTH V.CODY,J.PACE,K.CHISUM,A.ROSOWSKY JRNL TITL NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF JRNL TITL 2 PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND JRNL TITL 3 TWO HIGHLY POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) TRIMETHOPRIM JRNL TITL 4 DERIVATIVES REVEALS CONFORMATIONAL CORRELATIONS WITH JRNL TITL 5 ACTIVITY AND NOVEL PARALLEL RING STACKING INTERACTIONS. JRNL REF PROTEINS V. 65 959 2006 JRNL REFN ISSN 0887-3585 JRNL PMID 17019704 JRNL DOI 10.1002/PROT.21131 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 10.0 REMARK 3 NUMBER OF REFLECTIONS : 18185 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.274 REMARK 3 FREE R VALUE : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1971 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1686 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.130 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.540 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.580 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : COE-221.PARAM REMARK 3 PARAMETER FILE 3 : DHF_PAR.TXT REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: WATERS PICKED AT LEVEL GREATER THAN 3.0 REMARK 4 REMARK 4 2FZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036498. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.906 REMARK 200 MONOCHROMATOR : RH COATED SI MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20156 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2CD2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% PEG 2K, 46 MM MES, 100 MM KCL, PH REMARK 280 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.31250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASN A 83 REMARK 475 GLU A 84 REMARK 475 SER A 85 REMARK 475 LEU A 86 REMARK 475 ASP A 87 REMARK 475 LEU A 88 REMARK 475 GLY A 89 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C5' DH3 A 208 O HOH A 331 2.07 REMARK 500 NZ LYS A 170 O HOH A 242 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 2 -14.68 -168.82 REMARK 500 GLN A 3 40.88 -144.74 REMARK 500 ARG A 21 -117.09 -126.46 REMARK 500 PRO A 26 24.21 -74.36 REMARK 500 GLU A 50 24.49 -140.51 REMARK 500 SER A 85 -75.61 -110.48 REMARK 500 LEU A 86 30.65 -144.22 REMARK 500 ASP A 87 101.83 -59.72 REMARK 500 ASN A 90 56.40 -118.55 REMARK 500 ASN A 118 -78.69 -103.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DH3 A 208 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CD2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE REMARK 900 COMPLEXES WITH FOLATE AND NADP+ REMARK 900 RELATED ID: 1U70 RELATED DB: PDB REMARK 900 MAGNESIUM DEPENDENT PHOSPHATASE 1 (MDP-1) REMARK 900 RELATED ID: 2FZH RELATED DB: PDB REMARK 900 PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO REMARK 900 HIGHLY POTENT TRIMETHOPRIM DERIVATIVES REMARK 900 RELATED ID: 2FZJ RELATED DB: PDB REMARK 900 PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO REMARK 900 HIGHLY POTENT TRIMETHOPRIM DERIVATIVES DBREF 2FZI A 1 206 UNP P16184 DYR_PNECA 1 206 SEQRES 1 A 206 MET ASN GLN GLN LYS SER LEU THR LEU ILE VAL ALA LEU SEQRES 2 A 206 THR THR SER TYR GLY ILE GLY ARG SER ASN SER LEU PRO SEQRES 3 A 206 TRP LYS LEU LYS LYS GLU ILE SER TYR PHE LYS ARG VAL SEQRES 4 A 206 THR SER PHE VAL PRO THR PHE ASP SER PHE GLU SER MET SEQRES 5 A 206 ASN VAL VAL LEU MET GLY ARG LYS THR TRP GLU SER ILE SEQRES 6 A 206 PRO LEU GLN PHE ARG PRO LEU LYS GLY ARG ILE ASN VAL SEQRES 7 A 206 VAL ILE THR ARG ASN GLU SER LEU ASP LEU GLY ASN GLY SEQRES 8 A 206 ILE HIS SER ALA LYS SER LEU ASP HIS ALA LEU GLU LEU SEQRES 9 A 206 LEU TYR ARG THR TYR GLY SER GLU SER SER VAL GLN ILE SEQRES 10 A 206 ASN ARG ILE PHE VAL ILE GLY GLY ALA GLN LEU TYR LYS SEQRES 11 A 206 ALA ALA MET ASP HIS PRO LYS LEU ASP ARG ILE MET ALA SEQRES 12 A 206 THR ILE ILE TYR LYS ASP ILE HIS CYS ASP VAL PHE PHE SEQRES 13 A 206 PRO LEU LYS PHE ARG ASP LYS GLU TRP SER SER VAL TRP SEQRES 14 A 206 LYS LYS GLU LYS HIS SER ASP LEU GLU SER TRP VAL GLY SEQRES 15 A 206 THR LYS VAL PRO HIS GLY LYS ILE ASN GLU ASP GLY PHE SEQRES 16 A 206 ASP TYR GLU PHE GLU MET TRP THR ARG ASP LEU HET NDP A 207 48 HET DH3 A 208 27 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM DH3 2,4-DIAMINO-5-[3',4'-DIMETHOXY-5'-(5-CARBOXYL-1- HETNAM 2 DH3 PENTYNYL)]BENZYL PYRIMIDINE FORMUL 2 NDP C21 H30 N7 O17 P3 FORMUL 3 DH3 C19 H22 N4 O4 FORMUL 4 HOH *171(H2 O) HELIX 1 1 LEU A 29 PHE A 42 1 14 HELIX 2 2 PHE A 46 PHE A 49 5 4 HELIX 3 3 ARG A 59 ILE A 65 1 7 HELIX 4 4 PRO A 66 ARG A 70 5 5 HELIX 5 5 SER A 97 TYR A 109 1 13 HELIX 6 6 GLY A 125 HIS A 135 1 11 HELIX 7 7 ASP A 162 SER A 166 5 5 HELIX 8 8 LYS A 173 GLY A 182 1 10 SHEET 1 A 8 HIS A 93 ALA A 95 0 SHEET 2 A 8 ARG A 75 ILE A 80 1 N VAL A 79 O ALA A 95 SHEET 3 A 8 SER A 51 GLY A 58 1 N MET A 57 O ILE A 80 SHEET 4 A 8 GLN A 116 GLY A 124 1 O PHE A 121 N LEU A 56 SHEET 5 A 8 LEU A 7 THR A 14 1 N ILE A 10 O VAL A 122 SHEET 6 A 8 LEU A 138 TYR A 147 1 O ARG A 140 N LEU A 9 SHEET 7 A 8 PHE A 195 THR A 203 -1 O TRP A 202 N ILE A 141 SHEET 8 A 8 LYS A 170 LYS A 171 -1 N LYS A 170 O THR A 203 SHEET 1 B 8 HIS A 93 ALA A 95 0 SHEET 2 B 8 ARG A 75 ILE A 80 1 N VAL A 79 O ALA A 95 SHEET 3 B 8 SER A 51 GLY A 58 1 N MET A 57 O ILE A 80 SHEET 4 B 8 GLN A 116 GLY A 124 1 O PHE A 121 N LEU A 56 SHEET 5 B 8 LEU A 7 THR A 14 1 N ILE A 10 O VAL A 122 SHEET 6 B 8 LEU A 138 TYR A 147 1 O ARG A 140 N LEU A 9 SHEET 7 B 8 PHE A 195 THR A 203 -1 O TRP A 202 N ILE A 141 SHEET 8 B 8 ILE A 190 GLU A 192 -1 N ILE A 190 O TYR A 197 SHEET 1 C 2 GLY A 18 GLY A 20 0 SHEET 2 C 2 VAL A 154 PHE A 155 -1 O VAL A 154 N ILE A 19 LINK OG SER A 64 C4B DH3 A 208 1555 1555 2.05 CISPEP 1 ARG A 70 PRO A 71 0 -0.22 SITE 1 AC1 30 VAL A 11 ALA A 12 ILE A 19 GLY A 20 SITE 2 AC1 30 ARG A 21 SER A 24 LEU A 25 TRP A 27 SITE 3 AC1 30 GLY A 58 ARG A 59 LYS A 60 THR A 61 SITE 4 AC1 30 ILE A 80 THR A 81 ARG A 82 LYS A 96 SITE 5 AC1 30 ILE A 123 GLY A 124 GLY A 125 ALA A 126 SITE 6 AC1 30 GLN A 127 LEU A 128 TYR A 129 ALA A 131 SITE 7 AC1 30 DH3 A 208 HOH A 214 HOH A 246 HOH A 311 SITE 8 AC1 30 HOH A 338 HOH A 376 SITE 1 AC2 18 ILE A 10 VAL A 11 ALA A 12 LEU A 25 SITE 2 AC2 18 GLU A 32 ILE A 33 PHE A 36 LYS A 37 SITE 3 AC2 18 SER A 64 PHE A 69 ARG A 75 ILE A 123 SITE 4 AC2 18 TYR A 129 THR A 144 NDP A 207 HOH A 237 SITE 5 AC2 18 HOH A 325 HOH A 331 CRYST1 36.970 42.625 60.397 90.00 95.02 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027049 0.000000 0.002376 0.00000 SCALE2 0.000000 0.023460 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016621 0.00000